10.1177/0960327116677355 63 LuC.ZhangF.XuW.WuX.LianN.JinH.et al (2015)
Es decir, la cantidad de frmaco que llega inalterada a la sangre es casi del 90 %
It is used to treat type 2 diabetes, and in higher doses, it can greatly assist with weight loss
Fatigue affects 5-11% of patients and typically results from substantial caloric restriction due to appetite suppression, gastrointestinal side effects like nausea and vomiting, dehydration from reduced oral intake, or rapid metabolic changes during weight loss
While semaglutide typically achieves 15-17% weight reduction in clinical studies, retatrutide powder demonstrates potential for 20-30% weight loss in substantial patient populations
As long as your treatment is working, you can stay at whatever dose works best for you